Enhancing anti-inflammatory cytokine IL-10 may be beneficial for acute coronary syndrome

Medical Hypotheses

Volumn 65, Issue 1, 2005, Pages 103-106

  Li, Jian Jun ^a   Guo, Yuan Lin ^a   Yang, Yue Jin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; C REACTIVE PROTEIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; MATRIX METALLOPROTEINASE; THROMBOPLASTIN;

APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CYTOKINE PRODUCTION; DISEASE COURSE; ENZYME SYNTHESIS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HYPOTHESIS; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE; TH2 CELL; TRANSCRIPTION INITIATION;

EID: 18944363861     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.01.030     Document Type: Article

References (30)

1. A. Maseri Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon N Engl J Med 336 1997 1014 1016
2. J.-J. Li Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis Med Hypotheses 63 2004 100 102
3. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1993 115 126
4. M.J. Davis Stability and unstability: the two faces of coronary atherosclerosis Circulation 94 1996 2013 2020
5. P.R. Moreno, E. Falk, and I.F. Palacios Macrophage infiltration in acute coronary syndromes: implications for plaque rupture Circulation 90 1994 775 780
6. P.K. Shah Inflammation, neointimal hyperplasia, and restenosis: as the leukocytes roll, the arteries thicken Circulation 107 2003 2175 2177
7. S.E. Alam, S.S. Nasser, K.E. Fernainy, A.A. Habib, and K.F. Badr Cytokine imbalance in acute coronary syndrome Curr Opin Pharmacol 4 2004 166 170
8. J.-J. Li, and C.-H. Fang C-reactive protein is not only a marker but also direct cause of cardiovascular disease Med Hypotheses 62 2004 499 506
9. P. Libby, and P.M. Ridker Novel inflammatory markers of coronary risk: theory versus practice Circulation 100 1999 1148 1150
10. J.-J. Li, H.-R. Wang, and C.-X. Huang Enhanced response of blood monocytes to C-reactive protein in patients with unstable angina Clin Chim Acta 352 2005 127 133
11. C.-H. Fang, and J.-J. Li Statin, like aspirin, should be given as early as possible in patients with acute coronary syndrome Med Hypotheses 64 2005 192 196
12. J.-J. Li, C.-H. Fang, and M.-Z. Cheng Activation of nuclear factor-κB and correlation with elevated plasma C-reactive protein in patients with unstable angina Heart Lung Circulation 13 2004 173 178
13. B. Schieffer, C. Bunte, and J. Witte Comparative effects of anti-antagonism and angiotensin converting enzyme inhibition on markers of inflammation, platelet aggregation in patients with coronary disease J Am Coll Cardiol 44 2004 362 368
14. D.A. Smith, S.D. Irving, J. Sheldon, and J.C. Kaski Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina Circulation 104 2001 746 750
15. C. Heeschen, S. Dimmeler, and C.W. Hamm Serum level of the anti-inflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes Circulation 107 2003 2109 2114
16. K. Mizia-Stee, Z. Gasior, and B. Zahorska-Markiewiez Serum tumor necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes Coron Artery Dis 14 2003 431 438
17. S. Fichtlscherer, S. Breuer, C. Heeschen, S. Dimmeler, and A. Zeiher Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease J Am Coll Cardiol 44 2004 50 52
18. P. Wang, P. Wu, and M.I. Siegel Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes: IL-10 and IL-4 suppress cytokine synthesis by different mechanisms J Biol Chem 270 1995 9558 9563
19. S. Lacraz, L.P. Nicod, and R. Chicheortiche IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human monoclear phagocytes J Clin Invest 96 1995 2304 2310
20. E. Lindmark, T. Tenno, and J. Chen IL-10 inhibits LPS-induced human monocyte tissue factor expression in whole blood Br J Haematol 102 1998 597 604
21. T. Arai, K. Hiromatus, and H. Nishimura Endogenous interleukin 10 prevent apoptosis in macrophages during Salmonella infection Biochem Biophys Res Commun 213 1995 600 607
22. L.J. Pinderski, M.P. Fishbein, and G. Subbanagounder Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient mice by altering lymphocyte and macrophage phenotypes Circ Res 90 2002 1064 1071
23. Z. Mallat, S. Besnard, and M. Duriez Protective role of interleukin-10 in atherosclerosis Circ Res 85 1999 e17 e24
24. L.J. Pinderski Oslund, C.C. Hedrick, and T. Olvera Interleukin-10 blocks atherosclerosis events in vitro and in vivo Atheroscler Thromb Vasc Biol 19 1999 2847 2853
25. Z. Yang, B. Zingarelli, and C. Szabo Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury Circulation 101 2000 1019 1026
26. J.K. Plenge, T.L. Hernandez, and K.M. Weil Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction Circulation 106 2002 1447 1452
27. J.-J. Li, M.-Z. Chen, X. Chen, and C.-H. Fang Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia Clin Cardiol 26 2003 472 476
28. J.-J. Li, and X.-J. Chen Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide Coron Artery Dis 14 2003 329 334
29. P.M. Ridker, N. Rifai, and S.P. Lowenthal Rapid reduction in C-reactive with cerivastatin among 785 patients with primary hypercholesterolemia Circulation 103 2001 1191 1193
30. Li J-J, Fang C-H, Hu S-S, et al. Effects of atorvastatin on anti-inflammatory cytokine interleukin-10 in patients with unstable angina within four weeks [submitted]